Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

See our updated masking policy

Stanford Health Care

Update on the treatment navigation for functional cure of chronic hepatitis B: expert consensus 2.0.

Update on the treatment navigation for functional cure of chronic hepatitis B: expert consensus 2.0. Clinical and molecular hepatology Wu, D., Kao, J. H., Piratvisuth, T., Wang, X., Kennedy, P. T., Otsuka, M., Ahn, S. H., Tanaka, Y., Wang, G., Yuan, Z., Li, W., Lim, Y. S., Niu, J., Lu, F., Zhang, W., Gao, Z., Kaewdech, A., Han, M., Yan, W., Ren, H., Hu, P., Shu, S., Kwo, P. Y., Wang, F. S., Yuen, M. F., Ning, Q. 2025

Abstract

As new evidence emerges, treatment strategies toward the functional cure of chronic hepatitis B are evolving. In 2019, a panel of national hepatologists published a Consensus Statement on the functional cure of chronic hepatitis B. Currently, an international group of hepatologists has been assembled to evaluate research since the publication of the original consensus, and to collaboratively develop the updated statements. The 2.0 Consensus was aimed to update the original consensus with the latest available studies, and provide a comprehensive overview of the current relevant scientific literatures regarding functional cure of hepatitis B, with a particular focus on issues that are not yet fully clarified. These cover the definition of functional cure of hepatitis B, its mechanisms and barriers, the effective strategies and treatment roadmap to achieve this endpoint, in particular new surrogate biomarkers used to measure efficacy or to predict response, the appropriate approach to pursuing a functional cure in special populations, the development of emerging antivirals and immunomodulators with potential for curing hepatitis B. The statements are primarily intended to offer international guidance for clinicians in their practice to enhance the functional cure rate of chronic hepatitis B.

View details for DOI 10.3350/cmh.2024.0780

View details for PubMedID 39838828